1992 Choi et al.
Asian J. Chem.
127.4, 124.0, 123.6, 121.4, 118.6, 102.6; MS (MOLDI-TOP),
m/z 361 (Anal. calcd. (%) for C, 66.50; H, 3.63; Br, 22.12; N,
7.75 Found (%); C, 66.53; H, 3.64; Br, 22.11; N, 7.72).
7-Bromo-4-phenyl-2-(pyridine-3-yl)quinolone (3b):
m.p.: 151-152 °C; 1H NMR (CDCl3, 200 MHz) δ7.9 (s, 1H),
7.8-7.9 (d, 1H), 7.6-7.7 (d, 1H), 7.5-7.6 (d, 1H), 7.4-7.5 (d,
1H), 7.3 (s, 1H), 7.0 (t, 1H), 6.9-7.0 (m, 6H); 13C NMR (CDCl3,
50MHz) δ154.5, 150.7, 149.5, 148.9, 144.4, 139.8, 134.6,
134.5, 131.0, 129.2,127.4, 121.2, 101.0; MS (MOLDI-TOP),
m/z 361 (Anal. calcd. (%) for C, 66.50; H, 3.63; Br, 22.12; N,
7.75 Found (%); C, 66.51; H, 3.62; Br, 30.10; N, 5.77).
7-Bromo-4-phenyl-2-(pyridine-4-yl)quinolone (3c):
m.p.: 139-140 °C; 1H NMR (CDCl3, 200 MHz) δ8.3 (d, 2H),
7.7 (d, 2H), 7.6-7.7 (d, 1H), 7.5 (d, 1H), 7.4 (s, 1H), 7.3-7.4 (t,
1H), 6.9-7.0 (m, 5H); 13C NMR (CDCl3, 50MHz) δ157.4,
150.3, 149.8, 145.7, 145.3, 139.8, 131.0, 130.6, 129.8, 129.2,
127.4, 124.0, 121.4, 118.6, 102.6; MS (MOLDI-TOP), m/z
361 (Anal. calcd. (%) for C, 66.50; H, 3.63; Br, 22.12; N, 7.75
Found (%); C, 66.46; H, 3.65; Br, 22.11; N, 7.78).
7-Bromo-4-phenyl-2-p-tolylquinolone (3i): m.p.: 144-
145 °C; 1H NMR (CDCl3, 200 MHz) δ8.1 (m, 3H), 7.6 (t, 1H),
7.5 (m, 3H), 7.4 (s, 1H), 7.3-7.4 (m, 2H), 6.6 (d, 2H), 2.4 (s,
3H); 13C NMR (CDCl3, 50 MHz) δ157.4, 150.3, 145.3, 139.8,
136.0, 131.0, 130.6, 130.3, 129.8, 129.5, 129.2, 127.4, 124.0,
1233, 118.6, 102.6, 21.3; MS (MOLDI-TOP), m/z 374.2 (Anal.
calcd. (%) for C, 70.60; H, 4.31; Br, 21.35; N, 3.74. Found
(%); C, 70.65; H, 4.29; Br, 21.34; N, 3.72).
7-Bromo-2-methylyl- 4-phenylquinolone (3j): m.p.:
122-123 °C; 1H NMR (CDCl3, 200 MHz) δ7.7 (d, 1H), 7.6 (d,
1H), 7.4-7.5 (m, 3H), 6.9-7.0 (t, 1H), 6.9 (s, 1H), 2.0 (s, 3H);
13C NMR (CDCl3, 50 MHz) δ160.0, 148.3, 145.0, 130.4, 129.5,
129.3, 127.4, 123.8, 120.9, 119.7; MS (MOLDI-TOP), m/z
298 (Anal. calcd. For C, 64.45; H, 4.06; Br, 26.80; N, 4.70
Found; C, 64.43; H, 4.08; Br, 26.80; N, 4.70).
General procedure for the preparation of dibenzo-
[b,f][1,5]diazocines (4): 2-Amino-4-bromobenzophenone (1.0
mmol) and 0.5 equivalents of DPP (0.5 mmol, purchased from
Aldrich) were mixed in the absence of any organic solvent
and then submitted for 3 min to microwave irradiation inside
a domestic microwave oven (Samsung, RE-555 TCW). The
work-up procedure is same as reported earlier10.After concen-
tration under reduced pressure, the residue was purified by
flash column chromatography on silica gel (EtOAc/n-hexane
= 1:20, v/v) to give the corresponding (5z,11z)-3,9-dibromo-
6,12-diphenyl-dibenzo[b,f][1,5]diazocine (4). m.p.: 190-192
°C; 1H NMR (CDCl3, 200 MHz) δ8.1-8.2 (d, 4H), 7.7 (d, 2H),
7.6-7.7 (t, 4H), 7.3-7.4 (d, 2H), 7.3 (t, 4H); 13C NMR (CDCl3,
50 MHz) δ131.8, 131.6, 131.2, 130.7, 129.2, 128.7, 128.2,
127.5, 123.1; MS (MOLDI-TOP), m/z 513.9 (Anal. calcd. (%)
for C, 66.49; H, 3.12; Br, 30.96; N, 5.43. Found (%); C, 66.48;
H, 3.10; Br, 30.99; N, 5.43).
7-Bromo-2-(furan-2-yl)-4-phenylquinolone (3d): m.p.:
122-125 °C; 1H NMR (CDCl3, 200 MHz) δ8.3 (s, 1H), 7.7 (d,
1H), 7.7 (d, 1H), 7.6-7.7 (m, 5H), 7.2-7.5 (m, 5H), 6.6 (t, 1H);
13C NMR (CDCl3, 50MHz) δ158.8, 157.7, 150.3, 145.3, 142.9,
139.8, 131.0, 130.6, 129.8, 129.2, 127.4, 124.0, 118.6, 112.0,
107.1, 102.6; MS (MOLDI-TOP), m/z 349 (Anal. calcd. (%)
for C, 65.16; H, 3.45; Br, 22.82; N, 4.00. Found (%); C, 65.11;
H, 3.47; Br, 22.83; N, 4.02).
7-Bromo-2-(furan-3-yl)-4-phenylquinolone (3e): m.p.:
1
126-127 °C; H NMR (CDCl3, 200 MHz) δ8.0 (s, 1H), 7.7-
7.9 (d, 2H), 7.5-7.9 (d, 2H), 7.5-7.6 (m, 4H), 7.2-7.5 (m, 4H),
6.2 (d, 1H); 13C NMR (CDCl3, 50MHz) δ157.4, 150.3, 145.3,
144.1, 139.8, 138.5, 131.0, 130.6, 129.8, 129.3, 129.2, 127.4,
124.0, 118.6, 108.8, 102.6; MS (MOLDI-TOP), m/z 349 (Anal.
calcd. (%) for C, 65.16; H, 3.45; Br, 22.82; N, 4.00. Found
(%); C, 65.16; H, 3.45; Br, 22.82; N, 4.00).
RESULTS AND DISCUSSION
Acetylpyridines, 2-acetylfuran, 2-acetylthiophene,
acetyimidazoles, acetone and 4-methyl-acetophenone were
condensed with 2-amino-4-bromobenzophenone (1) under the
above mentioned optimal reaction conditions. The results are
summarized in Table-1. Condensation of 2a-j with 1 afforded
quinolines in good yields (60.0-74.5 %); in these reactions,
(5z,11z)-3,9-dibromo-6,12-diphenyl-dibenzo[b,f][1,5]
diazocine (4) was isolated as the minor product. The effect of
microwave irradiation on quinoline formation can be explained
on the basis of microwave activation effects caused by dipole-
dipole interactions, mechanistic considerations and the increase
in the polarity of the system (P) during the progress of the
reaction9,10. 6,12-Diphenyl-dibenzo[b,f][1,5]diazocine (4) is
a minor product formed by the self-condensation (Q) of 1.
7-Bromo-4-phenyl-2-(thiophen-2-yl)quinolone (3f):
m.p.: 143-144 °C; 1H NMR (CDCl3, 200 MHz) δ8.6 (d, 1H),
7.7 (d, 1H), 7.6-7.7 (m, 6H), 7.6 (m, 3H), 7.3 (t, 1H); 13C
NMR (CDCl3, 50MHz) δ158.8, 150.3, 145.3, 142.4, 139.8,
131.0, 130.6, 129.8, 128.6, 128.0, 127.6, 124.0, 118.6, 102.6;
MS (MOLDI-TOP), m/z 366.3 (Anal. calcd. (%) for C, 62.30;
H, 3.30; Br, 21.82; N, 3.82; S, 8.75. Found (%); C, 62.30; H,
3.33; Br, 21.79; N, 3.81; S, 8.76).
7-Bromo-2(1H-imidazol-1-yl)-4-phenylquinoline (3g):
m.p.: 135-137 °C; 1H NMR (CDCl3, 200 MHz) δ7.7 (s, 1H),
7.6 (d, 1H), 7.5-7.6 (m, 3H), 7.3-7.5 (m, 5H), 6.9 (d, 2H); 13C
NMR (CDCl3, 50MHz) δ159.4, 150.0, 146.0, 143.5, 134.5,
131.0, 130.6, 129.8, 129.2, 127.8, 127.4, 124.0,121.2, 111.4;
MS (MOLDI-TOP), m/z 349 (Anal. calcd. (%) for C, 61.73;
H, 3.43; Br, 22.82; N, 12.00. Found (%); C, 61.72; H, 3.40;
Br, 22.83; N, 12.03).
7-Bromo-4-phenyl-2-(pyrazin-2-yl)quinolone (3h):
m.p.: 160-161 °C; 1H NMR (CDCl3, 200 MHz) δ8.2 (t, 3H),
7.9 (d, 1H), 7.7 (t, 1H), 7.5-7.7 (m, 4H), 7.1-7.3 (m, 3H); 13C
NMR (CDCl3, 50MHz) δ151.1, 150.3, 146.6, 145.3, 144.7,
144.4, 142.3, 139.8, 131.6, 129.8, 129.2, 127.4, 124.0, 118.6,
102.6; MS (MOLDI-TOP), m/z 361 (Anal. calcd. (%) for C,
63.00; H, 3.34; Br, 22.06; N, 11.6. Found (%); C, 62.98; H,
3.32; Br, 22.09; N, 11.61).
H
O
O
X
N
H
N
H
H
R
O
X
N
H
P
Q